These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39183194)

  • 1. Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients.
    Abouelkheir M; Aldawsari MR; Ghonem L; Almomen A; Alsarhani E; Alsubaie S; Alqahtani S; Kurdee Z; Alsultan A
    Eur J Clin Pharmacol; 2024 Nov; 80(11):1807-1817. PubMed ID: 39183194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
    Cojutti P; Pai MP; Pea F
    Clin Pharmacokinet; 2018 Aug; 57(8):989-1000. PubMed ID: 29080937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosage regimen and toxicity risk assessment of linezolid in sepsis patients.
    Dou L; Meng D; Dong Y; Chen L; Han X; Fan D; Dong H
    Int J Infect Dis; 2020 Jul; 96():105-111. PubMed ID: 32251797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
    Cojutti P; Maximova N; Crichiutti G; Isola M; Pea F
    J Antimicrob Chemother; 2015 Jan; 70(1):198-206. PubMed ID: 25182066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pharmacokinetic pharmacodynamic target attainment of meropenem in pediatric patients.
    Alsultan A; Aldawsari MR; Alturaiq NK; Syed SA; Alsubai A; Kurdee Z; Alsubaie S; Alqahtani S; Abouelkheir M
    Pediatr Neonatol; 2024 Jul; 65(4):386-390. PubMed ID: 38218717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients.
    Dong H; Xie J; Wang T; Chen L; Zeng X; Sun J; Wang X; Dong Y
    Int J Antimicrob Agents; 2016 Sep; 48(3):259-64. PubMed ID: 27474469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of linezolid and exploring optimal regimens and a toxicity-related nomogram in elderly patients: a multicentre, prospective, non-interventional study.
    Liu T; Yuan Y; Wang C; Wu J; Wang Y; Na P; Chen X; Rao W; Zhao J; Wang D; Wang H; Duan Z; Xie F; Fang X; Xie L; Li H
    J Antimicrob Chemother; 2024 Aug; 79(8):1938-1950. PubMed ID: 38873816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.
    Rao GG; Konicki R; Cattaneo D; Alffenaar JW; Marriott DJE; Neely M;
    Ther Drug Monit; 2020 Feb; 42(1):83-92. PubMed ID: 31652190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of target non-attainment in obese compared to non-obese patients in calculated linezolid therapy.
    Ehmann L; Simon P; Busse D; Petroff D; Dorn C; Huisinga W; Dietrich A; Zeitlinger M; Wrigge H; Kloft C
    Clin Microbiol Infect; 2020 Sep; 26(9):1222-1228. PubMed ID: 32311473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity.
    Luque S; Muñoz-Bermudez R; Echeverría-Esnal D; Sorli L; Campillo N; Martínez-Casanova J; González-Colominas E; Álvarez-Lerma F; Horcajada JP; Grau S; Roberts JA
    Ther Drug Monit; 2019 Dec; 41(6):732-739. PubMed ID: 31259884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients.
    Li SC; Ye Q; Xu H; Zhang L; Wang Y
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30642929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.
    Crass RL; Cojutti PG; Pai MP; Pea F
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy.
    Ide T; Takesue Y; Ikawa K; Morikawa N; Ueda T; Takahashi Y; Nakajima K; Takeda K; Nishi S
    Int J Antimicrob Agents; 2018 May; 51(5):745-751. PubMed ID: 29425834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review.
    Chiappini E; Conti C; Galli L; de Martino M
    Clin Ther; 2010 Jan; 32(1):66-88. PubMed ID: 20171414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients.
    Jung D; Kishk OA; Bhutta AT; Cummings GE; El Sahly HM; Virk MK; Moffett BS; Morris Daniel JL; Watanabe A; Fishbane N; Kotloff KL; Gu K; Ghazaryan V; Gobburu JVS; Akcan-Arikan A; Campbell JD
    Crit Care Explor; 2024 Oct; 6(10):e1159. PubMed ID: 39352409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
    Dong H; Xie J; Chen L; Wang T; Sun J; Zhao Y; Dong Y
    Int J Infect Dis; 2014 May; 22():35-40. PubMed ID: 24603161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of linezolid into synovial fluid and muscle tissue after elective arthroscopy.
    Schwameis R; Syré S; Sarahrudi K; Appelt A; Marhofer D; Burau D; Kloft C; Zeitlinger M
    J Antimicrob Chemother; 2017 Oct; 72(10):2817-2822. PubMed ID: 29091212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Linezolid Dose Adjustment for Creatinine Clearance in Critically Ill Patients: A Multicenter, Prospective, Open-Label, Observational Study.
    Wang X; Wang Y; Yao F; Chen S; Hou Y; Zheng Z; Luo J; Qiu B; Li Z; Wang Y; Wu Z; Lan J; Chen C
    Drug Des Devel Ther; 2021; 15():2129-2141. PubMed ID: 34040351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
    Velarde-Salcedo R; Pérez-González LF; Rodríguez-Báez AS; Arriaga-García FJ; Milán-Segovia RDC; Romano-Moreno S; Medellín-Garibay SE
    Eur J Pediatr; 2023 Sep; 182(9):4143-4152. PubMed ID: 37436522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.